As mentioned in the notes, corruption in the pharmaceutical supply chain is a constant concern not only to the industries reputation but also to the health and safety of the patients using the products (drugs or devices). Up to 40 million prescriptions are filled with counterfeits each year in the United States. The article linked to below is from the economist and is about corruption and counterfeit drugs in the industry and it’s impact:

http://www.economist.com/node/21564546

This infograph below from create.org (The Centre for Responsible Enterprise And TradE) also illustrates where the vulnerabilities lie within the supply chain.